NMRlipids:
  id: CER
  name: N-palmitoyl-D-erythro-sphingosine
  charge: 0
sameAs:
  pubchem.compound: 5283564
  chebi: CHEBI:72959
  lipidmaps: LMSP02010004
  metabolights: MTBLC72959
  slm: SLM:000000554
  pdb.ligand: 16C
bioschema_properties:
  name: N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide
  iupacName: N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide
  molecularFormula: C34H67NO3
  molecularWeight: 537.9
  inChI: InChI=1S/C34H67NO3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-33(37)32(31-36)35-34(38)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h27,29,32-33,36-37H,3-26,28,30-31H2,1-2H3,(H,35,38)/b29-27+/t32-,33+/m0/s1
  inChIKey: YDNKGFDKKRUKPY-TURZORIXSA-N
  smiles: CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@@H](/C=C/CCCCCCCCCCCCC)O
  image: https://www.ebi.ac.uk/chembl/api/data/image/CHEMBL35292?dimensions=200
  alternateName:
  - C16 Ceramide
  - C16-ceramide
  - DTXSID301317974
  - RefChem:573083
  - DTXCID501747767
  - 640-541-5
  - 24696-26-2
  - N-palmitoyl-D-erythro-sphingosine
  - Cer(d18:1/16:0)
  - N-palmitoyl-sphingosine
  - C16 Cer
  - N-(hexadecanoyl)-sphing-4-enine
  - N-acylsphingosine
  - N-(palmitoyl)-ceramide
  - N-(hexadecanoyl)-ceramide
  - N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide
  - CHEMBL35292
  - CHEBI:72959
  - N-((E,2s,3r)-1,3-Dihydroxyoctadec-4-En-2-Yl)palmitamide
  - Ceramide (Egg, Chicken)
  - N-PALMITOYL-D-SPHINGOSINE
  - C34H67NO3
  - N-hexadecanoyl-D-erythro-sphingosine
  - Hexadecanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-
  - N-Hexadecanoyl-D-sphingosine
  - C16 Ceramide (d18:1/16:0)
  - MFCD00056205
  - 477243-06-4
  - Ceramide d34:1
  - N-(palmitoyl)ceramide
  - N-hexadecanoylsphingosine
  - N-(hexadecanoyl)ceramide
  - N-palmitoylsphing-4-enine
  - FD38GFZ87C
  - N-hexadecanoylsphing-4-enine
  - sphing-4-enine-16-ceramide
  - BSPBio_001281
  - BML3-D03
  - N-(hexadecanoyl)sphing-4-enine
  - Ceramide (d18:1/16:0)
  - SCHEMBL10298591
  - Ceramide (18:1/16:0)
  - GLXC-15996
  - GLXC-27248
  - HMS1361A03
  - HMS1791A03
  - HMS1989A03
  - HMS3402A03
  - CUA24306
  - BDBM50289523
  - LMSP02010004
  - MSK005012
  - AKOS040755906
  - IDI1_033751
  - NCGC00161362-01
  - NCGC00161362-02
  - NCGC00161362-03
  - BP-28815
  - HY-100354
  - CS-0018668
  - N-Palmitoyl-D-sphingosine, >=98.0% (TLC)
  - G90989
  - C16 Ceramide (N-Palmitoylsphingosine, D-erythro)
  - N-((2S,3R,E)-1,3-dihydroxyoctadec-4-en-2-yl)palmitamide
  - N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide
  - C16 Ceramide (d18:1/16:0), N-palmitoyl-D-erythro-sphingosine, powder
  - N-[(E,1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadec-3-enyl]hexadecanamide
  - Hexadecanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-
  - Hexadecanoic acid ((E)-(1S,2R)-2-hydroxy-1-hydroxymethyl-heptadec-3-enyl)-amide
  - N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]hexadecanamide
  - N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]hexadecanamide
  - N-Palmitoyl-D-erythro-sphingosine;N-Hexadecanoyl-D-erythro-sphingosine;N-Palmitoyl
    ceramide
